S-1/A: Natures Miracle Holding Inc. Announces Proposed Public Offering of Units and Resale of Common Stock

Natures Miracle Holding Inc. plans to offer up to 25,746,653 units, each with common stock and warrants, and register 3,317,400 shares for resale by selling stockholders.

Summary

• Natures Miracle Holding Inc. is planning a public offering involving up to 25,746,653 units, each consisting of one share of common stock, one Series A warrant, and one Series B warrant.
• The company is also offering up to 25,746,653 pre-funded units as an alternative to the standard units for investors who would exceed ownership limits.
• Each pre-funded unit includes one pre-funded warrant, one Series A warrant, and one Series B warrant.
• The assumed public offering price is $0.0971 per unit, based on the closing price of the common stock on November 4, 2024.
• The Series A warrants have an exercise price of $0.0971 per share and expire 5 years after warrant stockholder approval, while Series B warrants have an exercise price of $0.0001 per share and expire 2 years after approval.
• The company is also registering 3,317,400 shares of common stock for resale by certain selling stockholders.
• The company intends to use the net proceeds from the offering for general corporate purposes, including working capital and investments.
• The company's common stock is listed on The Nasdaq Global Market under the symbol NMHI.
• The company has applied to list the registered warrants on The Nasdaq Capital Market under the symbol NMHIW.
• The company received a delisting notice from Nasdaq due to non-compliance with listing rules regarding market value of listed securities and publicly held shares, and has requested a hearing to appeal this determination.
• The company also received a notice from Nasdaq regarding non-compliance with the minimum bid price requirement, and intends to implement a reverse stock split to regain compliance.

Sentiment

Score: 4

Explanation: The document contains both positive and negative aspects. The company is attempting to raise capital and address Nasdaq compliance issues, but faces financial challenges and delisting risks.

Positives

• The offering aims to raise capital for general corporate purposes, including working capital and investments.
• The company is taking steps to regain compliance with Nasdaq listing requirements.

Negatives

• The company has received a delisting notice from Nasdaq due to non-compliance with listing rules.
• The company has also received a notice from Nasdaq regarding non-compliance with the minimum bid price requirement.
• There is no established trading market for the Units, Pre-Funded Units, Warrants or Pre-Funded Warrants.

Risks

• The company may not be able to continue to satisfy listing requirements of Nasdaq to maintain a listing of its common stock.
• The company has incurred substantial operating losses since 2022 and there is substantial doubt about its ability to continue as a going concern.
• The Warrants are speculative in nature.
• Stockholders may experience future dilution as a result of this and future equity offerings.
• The Companys stock price may fluctuate significantly.

Future Outlook

The company intends to use the net proceeds from this offering for general corporate purposes, including working capital and investments.

Industry Context

The company operates in the Controlled Environment Agriculture (CEA) industry, which is experiencing growth due to factors such as increased demand for fresh foods, the need for year-round farming, and efficient use of resources.

Comparison to Industry Standards

• The document mentions that certain types of greenhouses can yield 20 times the yield per acre than conventional farming, according to the U.S. Department of Agriculture.
• It also states that indoor farming can grow plants using ten times less water than soil farming, according to the U.S. National Park Service.
• The document does not provide specific comparisons to named competitors or projects.

Management Changes

Legal Proceedings

• Megaphoton has filed lawsuits against Natures Miracle and its subsidiaries, alleging breach of contract.
• Beverly Hills View, Inc. brought a lawsuit against our subsidiary Visiontech, in Los Angeles Superior Court, alleging that the lighting products BHV received were not suitable for its cannabis growing operation and claiming damages of $2,500,000. Visiontech cross-complained on October 30, 2024, for BHV failing to pay for products BHV purchased for $750,000.
• Growterra, LLC filed a complaint against the Company and the Companys chief executive officer in the Court of Common Pleas, Hamilton County, Ohio, alleging that it purchased lighting products from the Company, under which the Company would provide Growterra software, IP, and design documentation related to hydroponic containers and identify Growterra as an additional insured on the Companys product liability insurance. Growterra alleges the Company failed to perform these obligations. Growterra is alleging breach of contract, fraud, and misappropriation of trade secrets as well as related causes of action. Growterra does not state an amount of damages but is also seeking rescission.

Related Party Transactions

• Zhiyi (Jonathan) Zhang, the President, Director, and beneficial owner of approximately 18% of the Companys outstanding shares of common stock, is also the sole owner of Uninet Global Inc.
• On September 24, 2024, the Company entered into a trade payable forgiveness agreement with Visiontech, Uninet Global Inc., and Natures Miracle, Inc., relating to the cancellation of a portion of outstanding trade payables owed by Visiontech to Uninet.
• Visiontech owed Uninet Global Inc. a trade payable in the amount of $2,713,073 as of June 30, 2024. Pursuant to the trade payable forgiveness agreement, Uninet Global Inc. agreed to cancel the outstanding trade payable of $2,135,573, leaving a remaining balance of $577,500 still payable by Visiontech to Uninet Global Inc.

Stakeholder Impact

• Shareholders may experience dilution as a result of the offering.
• The company's ability to provide equity incentives to its employees may be impaired if its common stock is delisted from Nasdaq.
• The company's ability to raise equity financing may be negatively impacted if its common stock is delisted from Nasdaq.

Next Steps

• The company will present a plan to regain compliance with Nasdaq continued listing requirements at a hearing on December 17, 2024.
• The company intends to implement a reverse stock split to regain compliance with the minimum bid price requirement.
• The company intends to use the net proceeds from this offering for general corporate purposes, including working capital and investments.
• The company intends to promptly seek stockholder approval for the Warrants.

Key Dates

Keywords

public offering, units, warrants, common stock, Natures Miracle, pre-funded units, delisting notice, Nasdaq, resale, securities